Clinical Trial Update: Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing tocotrienol as a nutritional supplement in patients with advanced ovarian cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: Vejle Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED